Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
Author(s) -
Sally Worsley,
Liz Hardaker,
James F. Donohue,
Alison Church,
Changqing Zhu
Publication year - 2021
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/9p1m-pz88
Subject(s) - fluticasone propionate , copd , medicine , salmeterol , lung function , fluticasone , anesthesia , lung , inhalation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom